TAC T-cell therapy is a new cancer treatment option. Researchers are studying it to treat both solid tumors and blood cancers, including multiple myeloma. If it gets FDA approval, this treatment would ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed the last ...

Abstract: Rate-splitting multiple access (RSMA) emerges as a promising beyond 5G (B5G) network technology for ultrareliable low-latency communication (URLLC). It splits messages into private and ...

Over the past day or so, free Gemini app users have lost the ability to upload files when using Gemini 2.5 Flash (preview). Update: This issue was resolved by the end of Saturday. On Android and iOS, ...

Three years after the first FDA approval of CAR-T cell therapy, patients with multiple myeloma are starting to see the therapy emerge in earlier lines. An innovative and groundbreaking cancer ...

Daniel Verina, DNP, ACNP-BC, discussed how CAR T-cell therapy is changing the treatment landscape for patients with multiple myeloma. CAR T-cell therapy represents a significant advancement in the ...

Myeloid Therapeutics, Inc., a clinical stage immunology company, announced multiple poster presentations at the American Society of Gene & Cell Therapy 2024 Annual Meeting, taking place May 7 – 11, ...

Relapse is common in multiple myeloma, and when it happens, a drug that worked for a patient before might no longer help. Two cell therapies already approved for this cancer may now be used in earlier ...